S2k guidelines: management of large-vessel vasculitis

被引：34

作者：

Schirmer, J. H. ^{[1
]}

Aries, P. M. ^{[2
]}

Balzer, K. ^{[3
]}

Berlit, P. ^{[4
]}

Bley, T. A. ^{[5
]}

Buttgereit, F. ^{[6
]}

Czihal, M. ^{[7
]}

Dechant, C. ^{[8
]}

Dejaco, C. ^{[9
]}

Garske, U. ^{[10
]}

Henes, J. ^{[11
]}

Holle, J. U. ^{[12
]}

Holl-Ulrich, K. ^{[13
]}

Lamprecht, P. ^{[14
]}

Noelle, B. ^{[15
]}

Moosig, F. ^{[12
]}

Rech, J. ^{[16
]}

Scheuermann, K. ^{[10
]}

Schmalzing, M. ^{[17
]}

Schmidt, W. A. ^{[18
]}

Schneider, M. ^{[19
]}

Schulze-Koops, H. ^{[8
]}

Venhoff, N. ^{[20
]}

Villiger, P. M. ^{[21
]}

Witte, T. ^{[22
]}

Zaenker, M. ^{[23
,24
]}

Hellmich, B. ^{[25
]}

机构：

[1] Univ Klinikum Schleswig Holstein, Klin Innere Med 1, Sekt Rheumatol, Exzellenzzentrum Entzundungsmed, Campus Kiel,Arnold Heller Str 3, D-24105 Kiel, Germany

[2] Rheumatol Struenseehaus, Hamburg, Germany

[3] GFO Kliniken Bonn, St Marien Hosp, Abt Gefass & Endovaskularchirurg, Bonn, Germany

[4] Deutsch Gesell Neurol, Berlin, Germany

[5] Univ Klinikum Wurzburg, Inst Diagnost & Interventionelle Radiol, Wurzburg, Germany

[6] Charite Univ Med Berlin, Med Klin Schwerpunkt Rheumatol & Klin Immunol CCM, Berlin, Germany

[7] Klinikum Univ Munchen, Sekt Angiol, Gefasszentrum, Med Klin & Poliklin 4, Munich, Germany

[8] Klinikum Univ Munchen, Sekt Rheumatol & Klin Immunol, Med Klin & Poliklin 4, Munich, Germany

[9] Med Univ Graz, Klin Abt Rheumatol & Immunol, Landesweiter Dienst Rheumatol, Sudtiroler Sanitatsbetrieb, Graz, Austria

[10] Deutsch Rheuma Liga Bundesverband eV, Bonn, Germany

[11] Univ Klinikum Tubingen, Rheumatol, Med Klin 2, Tubingen, Germany

[12] Rheumazentrum Schleswig Holstein Mitte, Neumunster, Germany

[13] Lab Lademannbogen MVZ, Pathol Hamburg, Hamburg, Germany

[14] Univ Lubeck, Klin Rheumatol & Klin Immunol, Lubeck, Germany

[15] Univ Klinikum Schleswig Holstein, Klin Ophthalmol, Campus Kiel, Kiel, Germany

[16] Univ Klinikum Erlangen, Med Klin Rheumatol & Immunol 3, Erlangen, Germany

[17] Univ Klinikum Wurzburg, Med Klin 2, Rheumatol Klin Immunol, Wurzburg, Germany

[18] Immanuel Krankenhaus Berlin Buch, Rheumatol & Klin Immunol, Berlin, Germany

[19] Univ Klinikum Dusseldorf, Poliklin & Funktionsbereich Rheumatol, Dusseldorf, Germany

[20] Albert Ludwigs Univ Freiburg, Klin Rheumatol & Klin Immunol, Vaskulitis Zentrum Freiburg, Dept Innere Med,Univ Klinikum Freiburg,Med Fak, Freiburg, Germany

[21] Inselspital Bern, Univ Klin Rheumatol Immunol & Allergol, Bern, Switzerland

[22] Hannover Med Sch, Klin Immunol & Rheumatol, Hannover, Germany

[23] Immanuel Klinikum Bernau Herzzentrum Brandenburg, Abt Innere Med, Bernau, Germany

[24] Med Hsch Brandenburg, Neuruppin, Germany

[25] Medius Klin, Klin Innere Med Rheumatol & Immunol, Vaskulitiszentrum Sud, Kirchheim, Germany

来源：

ZEITSCHRIFT FUR RHEUMATOLOGIE | 2020年 / 79卷 / SUPPL 3期

关键词：

GIANT-CELL ARTERITIS; REFRACTORY TAKAYASU ARTERITIS; QUALITY-OF-LIFE; SEVERE ISCHEMIC COMPLICATIONS; POSITRON-EMISSION-TOMOGRAPHY; PLACEBO-CONTROLLED TRIAL; PERCUTANEOUS CORONARY INTERVENTION; RHEUMATOLOGY; 1990; CRITERIA; COLOR DUPLEX SONOGRAPHY; POPULATION-BASED COHORT;

D O I：

10.1007/s00393-020-00893-1

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

[No abstract available]

引用

页码：67 / 95

页数：29

共 281 条

[1] Tocilizumab in refractory Takayasu arteritis: A case series and updated literature review
Abisror, Noemie
Mekinian, Arsene
Lavigne, Christian
Vandenhende, Marie-Anne
Soussan, Michael
Fain, Olivier
[J]. AUTOIMMUNITY REVIEWS, 2013, 12 (12) : 1143 - 1149
[2] Quality of life of patients with Takayasu's arteritis
Abularrage, Christopher J.
Slidell, Mark B.
Sidawy, Anton N.
Kreishman, Peter
Amdur, Richard L.
Arora, Subodh
[J]. JOURNAL OF VASCULAR SURGERY, 2008, 47 (01) : 131 - 136
[3] HOW DOES PREVIOUS CORTICOSTEROID TREATMENT AFFECT THE BIOPSY FINDINGS IN GIANT-CELL (TEMPORAL) ARTERITIS
ACHKAR, AA
LIE, JT
HUNDER, GG
OFALLON, WM
GABRIEL, SE
[J]. ANNALS OF INTERNAL MEDICINE, 1994, 120 (12) : 987 - 992
[4] Surgical management of aortic regurgitation associated with Takayasu arteritis and other forms of aortitis
Adachi, Osamu
Saiki, Yoshikatsu
Akasaka, Junetsu
Oda, Katsuhiko
Iguchi, Atsushi
Tabayashi, Koichi
[J]. ANNALS OF THORACIC SURGERY, 2007, 84 (06) : 1950 - 1954
[5] Efficacy and tolerability of leflunomide in difficult-to-treat polymyalgia rheumatica and giant cell arteritis: a case series
Adizie, T.
Christidis, D.
Dharmapaliah, C.
Borg, F.
Dasgupta, B.
[J]. INTERNATIONAL JOURNAL OF CLINICAL PRACTICE, 2012, 66 (09) : 906 - 909
[6] Risk of relapse after discontinuation of tocilizumab therapy in giant cell arteritis
Adler, Sabine
Reichenbach, Stephan
Gloor, Andrea
Yerly, Daniel
Cullmann, Jennifer L.
Villiger, Peter M.
[J]. RHEUMATOLOGY, 2019, 58 (09) : 1639 - 1643
[7] Management of Takayasu arteritis: a systematic literature review informing the 2018 update of the EULAR recommendation for the management of large vessel vasculitis
Agueda, Ana F.
Monti, Sara
Luqmani, Raashid Ahmed
Buttgereit, Frank
Cid, Maria
Dasgupta, Bhaskar
Dejaco, Christian
Mahr, Alfred
Ponte, Cristina
Salvarani, Carlo
Schmidt, Wolfgang
Hellmich, Bernhard
[J]. RMD OPEN, 2019, 5 (02):
[8] AIELLO PD, 1993, OPHTHALMOLOGY, V100, P550
[9] Relapses in Patients With Giant Cell Arteritis Prevalence, Characteristics, and Associated Clinical Findings in a Longitudinally Followed Cohort of 106 Patients
Alba, Marco A.
Garcia-Martinez, Ana
Prieto-Gonzalez, Sergio
Tavera-Bahillo, Itziar
Corbera-Bellalta, Marc
Planas-Rigol, Ester
Espigol-Frigole, Georgina
Butjosa, Montserrat
Hernandez-Rodriguez, Jose
Cid, Maria C.
[J]. MEDICINE, 2014, 93 (05) : 194 - 201
[10] Severe Intracranial Involvement in Giant Cell Arteritis: 5 Cases and Literature Review
Alsolaimani, Roaa S.
Bhavsar, Sankalp V.
Khalidi, Nader A.
Pagnoux, Christian
Mandzia, Jennifer L.
Tay, KengYeow
Barra, Lillian J.
[J]. JOURNAL OF RHEUMATOLOGY, 2016, 43 (03) : 648 - 656

← 1 2 3 4 5 6 7 8 9 10 →